AMSilk’s quality management receives certification according to the international medical devices standard DIN EN ISO 13485:2016
AMSilk GmbH, the world’s first industrial supplier of synthetic silk biopolymers, today announced that its quality management system for the first time has received certification according to DIN EN ISO 13485:2016 by the TÜV Süd. This international standard describes special requirements for quality management systems of medical device manufacturers and their suppliers. With this certification, TÜV Süd confirms that AMSilk is a qualified supplier for medical device manufacturers and that it implements stringent industry standards concerning safety and reliability of its products as well as the required risk management procedures.
Moreover, TÜV Süd recertified AMSilk regarding conformity with the international standard ISO 9001:2015.
Jens Klein, AMSilk CEO, welcomed the certifications as validation of AMSilk’s longstanding commitment to quality management: “We are very pleased that our high standards regarding safety and product quality have been reconfirmed by the TÜV certification. As AMSilk is planning to further reinforce and develop its medical technology business unit, especially the certification according to DIN EN ISO 13485:2016 is an essential milestone in the development of best-in- class products.”
AMSilk GmbH is the world’s first industrial supplier of synthetic silk biopolymers and has its headquarters in Planegg near Munich, Germany. Sustainably produced using a patented biotechnological process, AMSilk high-performance biopolymers have the unique functional properties of the natural product they are based on. The organic high-performance material can be used in multiple ways, including in medical or technical products as well as cosmetic ingredients. AMSilk high-performance biopolymers give everyday products unique properties. Among other things, the polymers are biocompatible, breathable and especially robust.
AMSilk high-performance biopolymers are distributed in the form of Silkbeads (microparticles), Silkgel (hydrogel) or Biosteel® fibers. They are currently used in coatings for medical technology products, in the textile industry and as an ingredient in cosmetic products.
AMSilk GmbH
Anja Mayer
Phone: +49 (0)89 57 95 393-0
Email: pr@amsilk.com
Kirchhoff Consult AG
Anja Ben Lekhal
Tel: +49 (0)40 60 91 86-55
E-mail: anja.benlekhal@kirchhoff.de
09.03.2026 | Neuried/Munich, Germany, announced that its bioengineered yarns are featured in commercially available garments within Balenciaga’s Spring 2026 collection.
03.09.2024 | AMSilk announces it has been invited to join the World Economic Forum’s Global Innovators Community, an invite-only initiative, that was established in 2019 to bring together companies making strides to innovate and contribute meaningfully to solving the key issues faced by people and the planet.
03.01.2022 | The use of a biotechnology-based and certified-vegan silk-like fabric marks a first in the automotive sector. Partnership with market leader underscores application potential of AMSilk’s technology.
